[go: up one dir, main page]

AU2001288829A1 - Degradable polyacetal polymers - Google Patents

Degradable polyacetal polymers

Info

Publication number
AU2001288829A1
AU2001288829A1 AU2001288829A AU8882901A AU2001288829A1 AU 2001288829 A1 AU2001288829 A1 AU 2001288829A1 AU 2001288829 A AU2001288829 A AU 2001288829A AU 8882901 A AU8882901 A AU 8882901A AU 2001288829 A1 AU2001288829 A1 AU 2001288829A1
Authority
AU
Australia
Prior art keywords
polymers
polyacetal polymers
degradable polyacetal
degradable
favorable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288829A
Inventor
Stephen Brocchini
Ruth Duncan
Shane Garrett
Jorge Heller
Marcus Klee
Ryan Tomlinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heron Therapeutics LLC
Original Assignee
AP Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AP Pharma Inc filed Critical AP Pharma Inc
Publication of AU2001288829A1 publication Critical patent/AU2001288829A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2/00—Addition polymers of aldehydes or cyclic oligomers thereof or of ketones; Addition copolymers thereof with less than 50 molar percent of other substances
    • C08G2/30—Chemical modification by after-treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G4/00—Condensation polymers of aldehydes or ketones with polyalcohols; Addition polymers of heterocyclic oxygen compounds containing in the ring at least once the grouping —O—C—O—
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L59/00—Compositions of polyacetals; Compositions of derivatives of polyacetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

Degradable polyacetal polymers and functionalized degradable polyacetal polymers have properties favorable for use in pharmaceutical and biomedical applications. The degradable polyacetal polymers are relatively stable at physiological pH with favorable biodistribution profiles, and degrade readily in low pH conditions. Conjugates of the polymers with drugs, especially anticancer drugs, and methods of treatment of cancer.
AU2001288829A 2000-09-06 2001-09-06 Degradable polyacetal polymers Abandoned AU2001288829A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23037700P 2000-09-06 2000-09-06
US60230377 2000-09-06
PCT/US2001/027664 WO2002020663A2 (en) 2000-09-06 2001-09-06 Degradable polyacetal polymers

Publications (1)

Publication Number Publication Date
AU2001288829A1 true AU2001288829A1 (en) 2002-03-22

Family

ID=22864985

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288829A Abandoned AU2001288829A1 (en) 2000-09-06 2001-09-06 Degradable polyacetal polymers

Country Status (8)

Country Link
US (1) US7220414B2 (en)
EP (1) EP1315777B1 (en)
AT (1) ATE377048T1 (en)
AU (1) AU2001288829A1 (en)
CA (1) CA2453050A1 (en)
DE (1) DE60131177T2 (en)
ES (1) ES2294026T3 (en)
WO (1) WO2002020663A2 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106098B2 (en) * 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
EP1315777B1 (en) * 2000-09-06 2007-10-31 AP Pharma, Inc. Degradable polyacetal polymers
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US6939561B2 (en) * 2001-06-28 2005-09-06 Wisconsin Alumni Research Foundation Methods and compositions for polyene antibiotics with reduced toxicity
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
AU2003209227A1 (en) 2002-01-14 2003-07-30 The General Hospital Corporation Biodegradable polyketal polymers and methods for their formation and use
WO2003082303A1 (en) * 2002-03-29 2003-10-09 Wisconsin Alumni Research Foundation Polymeric micelle formulations of hydrophobic compounds and methods
US8030459B2 (en) * 2002-07-19 2011-10-04 The General Hospital Corporation Oxime conjugates and methods for their formation and use
WO2004009774A2 (en) * 2002-07-19 2004-01-29 Amgen Inc. Protein conjugates with a water-soluble biocompatible, biogradable polymer
US7045589B2 (en) 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
US6878374B2 (en) 2003-02-25 2005-04-12 Nitto Denko Corporation Biodegradable polyacetals
US7332477B2 (en) * 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
US7048925B2 (en) 2003-08-28 2006-05-23 Nitto Denko Corporation Acid-sensitive polyacetals and methods
ATE507845T1 (en) 2003-09-05 2011-05-15 Gen Hospital Corp POLYACETAL DRUG CONJUGATES AS A RELEASE SYSTEM
JP4586022B2 (en) 2003-09-29 2010-11-24 日東電工株式会社 Biodegradable polyacetals for in vivo polynucleotide delivery
WO2005041987A1 (en) * 2003-10-29 2005-05-12 Gentis, Inc. Polymerizable emulsions for tissue engineering
GB0329654D0 (en) * 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
DE102004023117A1 (en) * 2004-05-11 2005-12-08 A. u. K. Müller GmbH & Co KG Solenoid valve for liquid media, especially hot water
US7358223B2 (en) * 2004-10-04 2008-04-15 Nitto Denko Corporation Biodegradable cationic polymers
JP4959570B2 (en) * 2004-10-18 2012-06-27 日東電工株式会社 Intracellular peptide delivery
US7674452B2 (en) 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
WO2006105148A2 (en) * 2005-03-31 2006-10-05 Ap Pharma, Inc. Peg-poly(ortho ester) graft copolymers and pharmaceutical compositions
CA2601546A1 (en) * 2005-03-31 2006-10-05 Ap Pharma, Inc. Peg-polyacetal diblock and triblock copolymers and pharmaceutical compositions
WO2006105172A2 (en) * 2005-03-31 2006-10-05 Ap Pharma, Inc. Peg-polyacetal and peg-polyacetal-poe graft copolymers and pharmaceutical compositions
US7588754B2 (en) * 2005-05-10 2009-09-15 Nitto Denko Corporation Biodegradable polyacetals and methods
US20060263328A1 (en) * 2005-05-19 2006-11-23 Sang Van Hydrophilic polymers with pendant functional groups and method thereof
JP2009511092A (en) * 2005-08-18 2009-03-19 スミス アンド ネフュー ピーエルシー Multimodal high-strength devices and composite materials
US20080305144A1 (en) * 2005-08-18 2008-12-11 Brown Malcolm Nmi High Strength Devices and Composites
US7700541B2 (en) * 2006-04-06 2010-04-20 Nitto Denko Corporation Biodegradable cationic polymers
CA2679365C (en) 2006-11-30 2016-05-03 Smith & Nephew, Inc. Fiber reinforced composite material
EP2125775A4 (en) * 2007-03-01 2011-07-13 Cedars Sinai Medical Center ANTIOXIDANT POLYMERS CONTAINING [1,2] -DITHIOLANE FRAGMENTS AND USES THEREOF
WO2008129245A1 (en) 2007-04-18 2008-10-30 Smith & Nephew Plc Expansion moulding of shape memory polymers
US9000066B2 (en) 2007-04-19 2015-04-07 Smith & Nephew, Inc. Multi-modal shape memory polymers
DE602008006181D1 (en) 2007-04-19 2011-05-26 Smith & Nephew Inc GRAFT FIXATION
US8658148B2 (en) * 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
US9028874B2 (en) * 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
US8603531B2 (en) 2008-06-02 2013-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of NSAIDs
EP2370435B1 (en) 2008-11-24 2015-01-07 Cedars-Sinai Medical Center Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
US8491880B2 (en) * 2008-12-10 2013-07-23 Mersana Therapeutics, Inc. Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates
US8347887B2 (en) 2008-12-23 2013-01-08 Ams Research Corporation Devices and methods for reversal of permanent sterilization
WO2012129070A2 (en) 2011-03-24 2012-09-27 Unversity Of Florida Research Foundation, Inc. Acetal metathesis polymerization
EP2508544A1 (en) 2011-04-04 2012-10-10 Argon Pharma S.L. Degradable polyacetal polymers
TWI603741B (en) 2011-06-10 2017-11-01 梅爾莎納醫療公司 Protein-polymer-drug conjugates
US8815226B2 (en) 2011-06-10 2014-08-26 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
WO2014008375A1 (en) * 2012-07-05 2014-01-09 Mersana Therapeutics, Inc. Terminally modified polymers and conjugates thereof
ES2754397T3 (en) 2013-10-11 2020-04-17 Asana Biosciences Llc Protein-polymer-drug conjugates
ES2726850T3 (en) 2013-10-11 2019-10-09 Mersana Therapeutics Inc Protein-polymer-drug conjugates
WO2016090103A1 (en) * 2014-12-04 2016-06-09 The Trustees Of Columbia University In The City Of New York Biodegradable thermo-responsive polymers and uses thereof
WO2017189953A1 (en) 2016-04-29 2017-11-02 Children's Medical Center Corporation Poly(ketals) and related compositions and methods

Family Cites Families (172)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US419156A (en) * 1890-01-07 mcgiehan
US322392A (en) * 1885-07-14 Telepher
US174411A (en) * 1876-03-07 Improvement in lamp-lighting devices
US37300A (en) * 1863-01-06 Improvement in window-blind fastenings
US152630A (en) * 1874-06-30 Improvement in cars for transporting coal
US19446A (en) * 1858-02-23 Money in cars
US471036A (en) * 1892-03-15 Feeding mechanism for sewing-machines
US54863A (en) * 1866-05-22 coghkan
US135929A (en) * 1873-02-18 Improvement in the manufacture of car-springs
US291668A (en) * 1884-01-08 Self-closing faucet
US77295A (en) * 1868-04-28 theqdoee krausch
US30444A (en) * 1860-10-16 william dopp
US176844A (en) * 1876-05-02 Improvement in beer-taps
US115734A (en) * 1871-06-06 Improvement in brick-kilns
US466566A (en) * 1892-01-05 jenny
US138474A (en) * 1873-05-06 Improvement in wave-powers
US151668A (en) * 1874-06-02 Improvement in machines for cutting paper
US64050A (en) * 1867-04-23 Samuel jacob wallace
US90398A (en) * 1869-05-25 Improvement in tree-boxes
US159A (en) * 1837-03-31 John swainson
US1482663A (en) * 1922-01-12 1924-02-05 Frederic A Shouldice Stone gatherer
US1579490A (en) * 1924-10-16 1926-04-06 Ke Haw Ke Mfg Company Tube-vulcanizing device
US2238477A (en) * 1940-01-06 1941-04-15 George E Murber Golf rubber overshoe
US2352547A (en) * 1941-12-19 1944-06-27 Pittsburgh Plate Glass Co ?fining of tall oil
US3268550A (en) 1963-08-26 1966-08-23 Ibm Nu-butenyl carbazoles
US4180064A (en) 1972-12-27 1979-12-25 Alza Corporation System for delivering agent to environment of use over prolonged time
FR2238477B1 (en) 1973-07-27 1976-12-03 Roussel Uclaf
US4014987A (en) 1974-06-04 1977-03-29 Alza Corporation Device for delivery of useful agent
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
FR2352547A1 (en) 1976-05-25 1977-12-23 Viridis Ets NEW ANIONIC RESIN WITH HYPOCHOLESTEROLEMIANTE ACTION, ITS PREPARATION PROCESS AND THERAPEUTIC COMPOSITIONS CONTAINING IT
US4152547A (en) * 1977-11-29 1979-05-01 Theis Peter F Selective monitor for an automatic telephone answering system
US4131662A (en) 1978-01-03 1978-12-26 Mobay Chemical Corporation Talc-based external mold release agent for polyurethane foams
US4261969A (en) 1979-05-03 1981-04-14 World Health Organization Controlled drug release composition
US4249531A (en) 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4502976A (en) 1982-10-25 1985-03-05 Bend Research, Inc. Water soluble polyesters
US4513143A (en) 1982-12-01 1985-04-23 Sri International Preparation of ketene acetals
US4690682A (en) 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US5449670A (en) 1983-05-20 1995-09-12 Skinner; Wilfred A. Composition and method for the transdermal delivery of bioactive peptides
US4710497A (en) 1983-05-20 1987-12-01 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents
US5128376A (en) 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4590190A (en) 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4752612A (en) 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4548990A (en) 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4605670A (en) 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
US4639366A (en) 1984-06-06 1987-01-27 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4765973A (en) * 1984-06-06 1988-08-23 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
GB8416234D0 (en) 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
US4549010A (en) 1984-06-27 1985-10-22 Merck & Co., Inc. Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal
GB8500209D0 (en) 1985-01-04 1985-02-13 Ceskoslovenska Akademie Ved Synthetic polymeric drugs
US4690825A (en) 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US4764364A (en) 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4855132A (en) 1986-02-25 1989-08-08 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4801457A (en) 1986-08-01 1989-01-31 Sandoz Pharm. Corp. Polyacetal hydrogels formed from divinyl ethers and polyols
US4713441A (en) * 1986-08-01 1987-12-15 Sandoz Pharmaceuticals Corp. Polyacetal hydrogels formed from divinyl ethers and polyols
US4849426A (en) 1987-05-15 1989-07-18 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents
US5013553A (en) 1987-06-30 1991-05-07 Vipont Pharmaceutical, Inc. Drug delivery devices
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US4923645A (en) 1987-11-16 1990-05-08 Damon Biotech, Inc. Sustained release of encapsulated molecules
SE8705136D0 (en) 1987-12-22 1987-12-22 Pharmacia Ab ORAL DOSAGE UNIT FOR MEDICINAL PRODUCTS AND ITS USE AND PREPARATION
US4898928A (en) * 1988-03-07 1990-02-06 Sandoz Pharmaceuticals Corp. Polyacetal and polyketal hydrogels formed from acetals or ketals and polyols
US4957998A (en) 1988-08-22 1990-09-18 Pharmaceutical Delivery Systems, Inc. Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5632727A (en) 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5725491A (en) 1988-10-03 1998-03-10 Atrix Laboratories, Inc. Method of forming a biodegradable film dressing on tissue
US5324520A (en) 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US4963369A (en) 1989-01-19 1990-10-16 Wm. Wrigley Jr. Co. Gum composition containing dispersed porous beads containing active chewing gum ingredients and method
US5108755A (en) 1989-04-27 1992-04-28 Sri International Biodegradable composites for internal medical use
DE69024953T3 (en) 1989-05-04 2005-01-27 Southern Research Institute, Birmingham encapsulation
US5028435A (en) 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
US5013821A (en) 1989-06-15 1991-05-07 Pharmaceutical Delivery Systems, Inc. Ortho and thio-ortho ester polymer
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5077049A (en) 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
US5030457A (en) 1989-08-28 1991-07-09 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
EP0489843A4 (en) 1989-08-28 1992-08-12 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
US5047464A (en) 1989-09-20 1991-09-10 Merck & Co., Inc. Bioerodible thermoset elastomers
US5217712A (en) 1989-09-20 1993-06-08 Merck & Co., Inc. Bioerodible thermoset elastomers
GB9007384D0 (en) 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
IL98087A (en) 1990-05-04 1996-11-14 Perio Prod Ltd Colonic drug delivery system
US5587507A (en) 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
SE9002339L (en) 1990-07-04 1992-01-05 Kabi Pharmacia Ab THERAPEUTIC COMPOSITION AND PROCEDURE FOR ITS PREPARATION
JP2773959B2 (en) 1990-07-10 1998-07-09 信越化学工業株式会社 Colon release solid preparation
NZ239370A (en) 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
MX9101786A (en) 1990-10-30 1992-06-05 Alza Corp DRUG SUPPLY SYSTEM AND METHOD
DE9015551U1 (en) 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Oral dosage form and coating agent containing a colon-degradable polysaccharide
US5422121A (en) 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
WO1993000383A1 (en) 1991-06-20 1993-01-07 Pharmaceutical Delivery Systems, Inc. Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions
HU222501B1 (en) * 1991-06-28 2003-07-28 Endorecherche Inc. For the preparation of a sustained release pharmaceutical composition and method comprising MPA or MGA
US5211951A (en) * 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP0560014A1 (en) 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5540912A (en) 1992-03-30 1996-07-30 Alza Corporation Viscous suspensions of controlled-release drug particles
US5334640A (en) 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5461140A (en) 1992-04-30 1995-10-24 Pharmaceutical Delivery Systems Bioerodible polymers for solid controlled release pharmaceutical compositions
EP0646019B9 (en) * 1992-06-09 2002-12-18 Neorx Corporation Biotin-DOTA conjugates and their use in pretargeting methods
GB9217331D0 (en) 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
GB2270920B (en) 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
MY113268A (en) 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
GB2282384B8 (en) 1993-08-18 1997-09-04 Europ Economic Community Drug delivery agents incorporating mitomycin
IL110787A0 (en) 1993-08-27 1994-11-11 Sandoz Ag Biodegradable polymer, its preparation and pharmaceutical composition containing it
US5681873A (en) 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
WO1995016659A1 (en) 1993-12-15 1995-06-22 Avon Products, Inc. Novel retinoid conjugate compounds and methods for treating skin aging
GB9402807D0 (en) 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9402809D0 (en) 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
IL112627A0 (en) 1994-02-14 1995-05-26 Xenova Ltd Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
GB9402805D0 (en) 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
ATE317690T1 (en) 1994-04-08 2006-03-15 Qlt Usa Inc LIQUID COMPOSITIONS FOR DRUG DELIVERY
DE4415204A1 (en) 1994-04-30 1995-11-02 Carl Heinrich Dr Weischer Compsns contg retinyl salicylate or acetyl-salicylate
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5607686A (en) 1994-11-22 1997-03-04 United States Surgical Corporation Polymeric composition
US6281015B1 (en) 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
GB9426090D0 (en) 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB9426224D0 (en) 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
US5891877A (en) 1995-02-14 1999-04-06 Xenova Limited Pharmaceutical compounds
US5627187A (en) 1995-04-12 1997-05-06 Katz; Bruce E. 5-FU for treating actinic kerotoses
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5877224A (en) 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
US6096344A (en) 1995-07-28 2000-08-01 Advanced Polymer Systems, Inc. Bioerodible porous compositions
WO1997007788A2 (en) 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
EP0869986B1 (en) 1996-01-05 2000-11-02 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
GB9600471D0 (en) 1996-01-10 1996-03-13 Univ London Pharmacy Drug delivery system
DE69615583T2 (en) 1996-01-16 2002-07-11 Advanced Polymer Systems, Inc. LOCAL DELIVERY OF MEDICINAL PRODUCTS IN DEEP GASTRIC SECTIONS
IL118235A0 (en) 1996-05-13 1996-09-12 Univ Ben Gurion Composition and method for forming biodegradable implants in situ and uses of these implants
AU739469B2 (en) 1996-12-20 2001-10-11 Alza Corporation Gel composition and methods
US5993856A (en) 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
UA54505C2 (en) 1997-04-03 2003-03-17 Гілфорд Фармасьютікалз Інк. Biodegradable polymers, bound by phosphates, compositions, products and pocesses for manufacturing and using thereof
AU7124598A (en) 1997-04-18 1998-11-13 Access Pharmaceuticals, Inc. Polymer-platinum compounds
US5965118A (en) 1997-04-18 1999-10-12 Access Pharmaceuticals, Inc. Polymer-platinum compounds
AU742255B2 (en) 1997-06-11 2001-12-20 School Of Pharmacy, University Of London, The Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs
AU8025998A (en) 1997-06-12 1998-12-30 Ml Laboratories Plc Biologically active materials
US6585956B2 (en) 1997-07-07 2003-07-01 The Dow Chemical Company Dendritic-platinate drug delivery system
US7005124B2 (en) 1997-07-07 2006-02-28 Dendritic Nanotechnologies, Inc. Dendritic-antineoplastic drug delivery system
US6193991B1 (en) 1997-10-29 2001-02-27 Atul J. Shukla Biodegradable delivery systems of biologically active substances
JP4312384B2 (en) 1998-04-13 2009-08-12 ラットガーズ ザ ステイト ユニヴァーシティ Construction of copolymer library
US6048736A (en) 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
US5939453A (en) 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
IL140005A0 (en) 1998-06-26 2002-02-10 Aventis Pharm Prod Inc Method of treatment for dermatological disorders and compositions therefor
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6159491A (en) 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6287588B1 (en) 1999-04-29 2001-09-11 Macromed, Inc. Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
EP1198253A2 (en) 1999-06-18 2002-04-24 ML Laboratories Plc Biologically active materials
US6822086B1 (en) * 1999-08-09 2004-11-23 The General Hospital Corporation Drug-carrier complexes and methods of use thereof
AU7025600A (en) 1999-09-08 2001-04-10 School Of Pharmacy, University Of London, The Uniform molecular weight polymers
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
WO2001036002A1 (en) 1999-11-17 2001-05-25 School Of Pharmacy, University Of London Conjugates of hpma copolymer and ellipticin
EP1118333A1 (en) 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
EP1142596A1 (en) 2000-04-03 2001-10-10 Universiteit Gent Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants
AU2001261516A1 (en) 2000-05-11 2001-11-20 Advanced Polymer Systems Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002002146A2 (en) 2000-07-01 2002-01-10 Ml Laboratories Plc Dextrin-amphotericin conjugates and their methods of preparation
EP1315777B1 (en) * 2000-09-06 2007-10-31 AP Pharma, Inc. Degradable polyacetal polymers
GB0030074D0 (en) 2000-12-08 2001-01-24 Univ London Pharmacy Particulate inhalation carrier
US20020176844A1 (en) 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
EP1395626A1 (en) 2001-05-11 2004-03-10 AP Pharma, Inc. Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
JP2005507933A (en) 2001-10-29 2005-03-24 ザ　ダウ　ケミカル　カンパニー Antineoplastic dendritic polymer drug delivery system
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
DE10157163A1 (en) 2001-11-22 2003-06-18 Gfe Gmbh & Co Kg Ges Fuer Ents Method and device for the disposal of materials containing high-energy substances, in particular grenades
GB0209022D0 (en) 2002-04-19 2002-05-29 Imp College Innovations Ltd Compounds

Also Published As

Publication number Publication date
US20020082362A1 (en) 2002-06-27
WO2002020663A3 (en) 2002-05-10
US7220414B2 (en) 2007-05-22
ES2294026T3 (en) 2008-04-01
WO2002020663A2 (en) 2002-03-14
CA2453050A1 (en) 2002-03-14
DE60131177D1 (en) 2007-12-13
DE60131177T2 (en) 2008-08-07
EP1315777B1 (en) 2007-10-31
ATE377048T1 (en) 2007-11-15
EP1315777A2 (en) 2003-06-04

Similar Documents

Publication Publication Date Title
AU2001288829A1 (en) Degradable polyacetal polymers
AU3468900A (en) Cyclodextrin polymers for use as drug carriers
AU6559800A (en) Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
WO2000064486A3 (en) Enzymatically activated polymeric drug conjugates
AU2003267581A1 (en) Drug delivery
MXPA02006220A (en) Hydrolytically degradable carbamate derivatives of poly(ethylene glycol).
TW200510454A (en) Conjugates comprising human IL-18 and substitution mutants thereof
BR0207378A (en) Cancer treatment
WO2003028657A3 (en) Compositions for oral gene therapy and methods of using same
MY129809A (en) Quinazoline derivatives
TNSN03137A1 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING LOW SOLUBILITY AND / OR ACID SENSITIVE DRUGS AND NEUTRALIZED ACID POLYMERS.
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
WO2003011226A3 (en) Products and drug delivery vehicles
GB2451599A (en) Nanostructures suitable for delivery of agents
WO2004098564A3 (en) Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide
WO2004056852A3 (en) Cyanovirin variant-polymer conjugates
EP2161037A3 (en) Camptothecin-Somatostatin conjugates
WO2003097106A3 (en) Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent
EP1201247A3 (en) Treatment of tumor metastases and cancer
WO2000078355A3 (en) Biologically active materials
AU7538700A (en) 5-hydroxysapogenin derivatives with anti-dementia activity
WO2005041881A8 (en) Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
EP1208840A3 (en) Combination of fluorouracil and a methylol transfer agent for the treatment of tumor metastases and cancer
WO2005002516A3 (en) Leukocyte internalized peptide-drug conjugates